Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aqua Pharmaceuticals, a West Chester based specialty pharmaceutical company focusing on acquiring, developing and marketing prescription dermatology products, has appointed Skip Williams as executive director of Product Development.
Subscribe to our email newsletter
Williams joins Aqua following an executive director position at Watson Pharmaceuticals, where he was responsible for brand and biologics business development since 2004.
In that role, Williams developed new products for Watson’s nephrology practice, spearheaded its entry into biologics and directed the rationalisation and disposition of the company’s dermatology business.
Prior to Watson, Williams was senior director of Acquisitions at Lexis-Nexis Martindale Hubbell where he directed new product development through acquisitions.
Williams spent 15 years in the pharmaceutical industry in leadership positions at both System Software Associates, where he was global head of its Pharmaceutical Practice and Accenture, where he rose to senior manager in its pharmaceutical group.
Aqua CEO Jay Gooding said that they were excited to bring Williams on to their senior management team.
"We believe his foundational experience, gained at both Watson and other healthcare organisations, will prove invaluable to Aqua and our organisational objectives," Gooding said.